₹ 1.1 Cr
Volume Transacted
(Nov 21, 2024)
11.2 K
Stocks Traded
(Nov 21, 2024)
Last Updated on: Nov 21, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
21 Nov 2024 | 944.25 | 947.6 | 950 | 933.25 |
19 Nov 2024 | 946.9 | 954 | 955 | 941.65 |
18 Nov 2024 | 944.95 | 960.05 | 965 | 939 |
14 Nov 2024 | 958.05 | 962.55 | 976.05 | 953.95 |
13 Nov 2024 | 963.6 | 950.15 | 968.95 | 946.6 |
12 Nov 2024 | 950.1 | 980 | 990.2 | 934.05 |
11 Nov 2024 | 968.55 | 965.55 | 975.4 | 962.55 |
08 Nov 2024 | 968.65 | 974.05 | 980.85 | 965 |
07 Nov 2024 | 972.6 | 1009.8 | 1009.8 | 969.3 |
06 Nov 2024 | 995 | 988.5 | 1003.45 | 987.25 |
Date | Price (₹) |
---|---|
21 Nov 2024 | 944.25 |
19 Nov 2024 | 946.9 |
18 Nov 2024 | 944.95 |
14 Nov 2024 | 958.05 |
13 Nov 2024 | 963.6 |
12 Nov 2024 | 950.1 |
11 Nov 2024 | 968.55 |
08 Nov 2024 | 968.65 |
07 Nov 2024 | 972.6 |
06 Nov 2024 | 995 |
Zydus Life Q2 PAT rises 14% YoY to Rs 911 cr
Revenue from operations grew 19.87% year on year (YoY) to Rs 5,237 crore in the quarter en...
12 Nov 202415:22
Zydus Lifesciences to table results
Zydus Lifesciences will hold a meeting of the Board of Directors of the Company on 12 Nove...
31 Oct 202411:58
Zydus Life rises on in-principle approval from WHO for typhoid vaccine
ZyVac TCV is now eligible for purchase by United Nations (UN) agencies. It is indigenously...
23 Oct 202414:50
Zydus receives USFDA approval for Fludrocortisone Acetate Tablets
Zydus Lifesciences has received final approval from the United States Food and Drug Admini...
18 Oct 202409:29
Zydus Life gets final approval from USFDA for Fludrocortisone Acetate tab
Fludrocortisone Acetate tablets are indicated as partial replacement therapy for primary a...
18 Oct 202412:47
Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease
Zydus Lifesciences has formalized the Memorandum of Agreement (MoA) with Indian Council of...
15 Oct 202410:08
Concalls
Unlimited trading at just
Rs. 199*